<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01827566</url>
  </required_header>
  <id_info>
    <org_study_id>GE-2012-GS</org_study_id>
    <nct_id>NCT01827566</nct_id>
  </id_info>
  <brief_title>Prevalence of Non Celiac Gluten Sensitivity Among Patients Spontaneously Adherent to Gluten Free Diet</brief_title>
  <official_title>Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial With a Cross-over Design to Assess the Prevalence of Non Celiac Gluten Sensitivity Among Patients Spontaneously Adherent to Gluten Free Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi di Brescia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi di Brescia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the prevalence of Gluten Sensitivity, by a
      double-blind placebo-controlled challenge with gluten, followed by two months period of
      Low-FODMAPs (Fermentable Oligosaccharides Disaccharides Monosaccharides And Polyols) diet, in
      patients spontaneously adherent to gluten free diet because of symptoms upon gluten exposure
      and in whom diagnosis of Celiac Disease and Wheat Allergy has been ruled out.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2012</start_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient's ability to correctly identify the phase with gluten</measure>
    <time_frame>Time (days) 35</time_frame>
    <description>time 0: start of first challenge (phase A, either with gluten or gluten free flour)
time 10: end of phase A and start of wash-out period
time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)
time 35: end of phase B</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in serum level of anti-tissue transglutaminases immunoglobulin A (IgA)/immunoglobulin G (IgG) and of anti-gliadin IgA/IgG</measure>
    <time_frame>Time (days) 0, 10, 25, 35</time_frame>
    <description>time 0: start of first challenge (phase A, either with gluten or gluten free flour)
time 10: end of phase A and start of wash-out period
time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)
time 35: end of phase B</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fatigue Visual Scale</measure>
    <time_frame>Time (days) 0, 10, 25, 35</time_frame>
    <description>time 0: start of first challenge (phase A, either with gluten or gluten free flour)
time 10: end of phase A and start of wash-out period
time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)
time 35: end of phase B</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Gastrointestinal Rating Score (GSRS) during Challenge with and without gluten</measure>
    <time_frame>Time (days) 0,10, 25, 35</time_frame>
    <description>Time 0: Start of first challenge (phase A, either with gluten or gluten free flour)
Time 10: end of phase A and start of wash-out period
Time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)
Time 35: end of phase B
At the beginning of Low-FODMAPs diet
After two months of Low-FODMAPs diet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in symptoms' score (1 to 7 Likert scale) as recorded on a daily diary</measure>
    <time_frame>From Time 0 (days) to 10 and from 25 to 35</time_frame>
    <description>time 0: start of first challenge (phase A, either with gluten or gluten free flour)
time 10: end of phase A and start of wash-out period
time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)
time 35: end of phase B</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Non Celiac Gluten Sensitivity</condition>
  <arm_group>
    <arm_group_label>gluten</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 grams of gluten in each sachet to be dispersed daily on food for ten days, while maintaining a gluten free diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>gluten free flour</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 grams of gluten free flour in each sachet to be dispersed daily on food for ten days, while maintaining a gluten free diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>gluten</intervention_name>
    <arm_group_label>gluten</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>gluten free flour</intervention_name>
    <arm_group_label>gluten free flour</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adherence to gluten free diet without medical need

          -  Negative Celiac Disease related serology (while on gluten containing diet)

          -  Normal villous structure at duodenal biopsy (while on gluten containing diet)

        Exclusion Criteria:

          -  Diagnosis of Celiac Disease

          -  Diagnosis of Wheat Allergy

          -  Diagnosis of organic gastrointestinal disease

          -  Severe concomitant disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alberto Lanzini, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Brescia, Unit of Gastroenterology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barbara Zanini, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Brescia, Unit of Gastroenterology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chiara Ricci, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Brescia, Unit of Gastroenterology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University and Spedali Civili of Brescia, Unit of Gastroenterology</name>
      <address>
        <city>Brescia</city>
        <zip>I-25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2013</study_first_submitted>
  <study_first_submitted_qc>April 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2013</study_first_posted>
  <last_update_submitted>December 5, 2014</last_update_submitted>
  <last_update_submitted_qc>December 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi di Brescia</investigator_affiliation>
    <investigator_full_name>Alberto Lanzini, MD PhD</investigator_full_name>
    <investigator_title>Associate Professor of Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Celiac Disease</keyword>
  <keyword>Gluten Sensitivity</keyword>
  <keyword>Gluten</keyword>
  <keyword>Double-blind challenge, placebo-controlled challenge</keyword>
  <keyword>Gluten free flour</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

